RAPT Therapeutics Inc

NASDAQ:RAPT  
18.57
-0.12 (-0.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)461.44M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.93 Million
Adjusted EPS-$0.72
See more estimates
10-Day MA$18.70
50-Day MA$20.47
200-Day MA$24.08
See more pivots

RAPT Therapeutics Inc Stock, NASDAQ:RAPT

561 Eccles Avenue, South San Francisco, California 94080
United States of America
Phone: +1.650.489.9000
Number of Employees: 68

Description

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.